XOMA Co. (NASDAQ:XOMAO) Sees Significant Decline in Short Interest

XOMA Co. (NASDAQ:XOMAO) was the recipient of a large decrease in short interest during the month of January. As of January 15th, there was short interest totaling 5,711 shares, a decrease of 37.6% from the December 31st total of 9,148 shares. Based on an average daily volume of 4,276 shares, the short-interest ratio is presently 1.3 days. Based on an average daily volume of 4,276 shares, the short-interest ratio is presently 1.3 days.

XOMA Stock Performance

Shares of XOMAO stock opened at $25.50 on Friday. The stock’s fifty day moving average price is $25.41 and its 200 day moving average price is $25.43. XOMA has a 1-year low of $23.32 and a 1-year high of $25.76.

About XOMA

XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.

In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.